🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

22 recruiting trials

for Factor VIII Deficiency, Congenital

Hemlibra in Mild Hemophilia A NCT04567511Phase 41 site📍 Indianapolis Indiana Hemophilia &Thrombosis Center, Inc. · Tests: Emicizumab Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients. NCT07437404Phase 31 site📍 Beijing Sinocelltech Ltd. · Tests: SCT800 prophylaxis and treatment for bleeding events A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI NCT02207894n/a1 site📍 Frankfurt am Main Haemophilia Centre Rhine Main ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders NCT04398628n/a76 sites📍 Phoenix📍 Little Rock📍 Los Angeles American Thrombosis and Hemostasis Network Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients NCT03695978n/a59 sites📍 Miami📍 New Orleans📍 St Louis Octapharma Embolization in Hereditary Coagulopathies NCT05629130NA1 site📍 São Paulo University of Sao Paulo General Hospital · Tests: embolization with spherical microparticles embosphere Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study NCT05935358Phase 418 sites📍 Dallas📍 Zagreb📍 Helsinki Octapharma · Tests: Nuwiq A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency) NCT06349473Phase 110 sites📍 Glendale📍 Los Angeles📍 Chicago Equilibra Bioscience LLC · Tests: SR604, Placebo A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A NCT07220564Phase 133 sites📍 Aurora📍 Indianapolis📍 Iowa City Novo Nordisk A/S · Tests: NNC0442-0344 A Prevalence of Synovitis in Patients With Haemophilia A NCT06352216n/a1 site📍 Bonn University Hospital, Bonn · Tests: Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US); Haemophilia joint health score (HJHS) Treatment of Hemophilia A Patients With FVIII Inhibitors NCT04023019n/a2 sites📍 Atlanta📍 Mörfelden-Walldorf Emory University · Tests: Nuwiq, Octanate, Wilate, Emicizumab, Recombinant factor VIIa (rFVIIa) Long-term Anticoagulation in a Patient With Severe Hemophilia A NCT07314983n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®) NCT07723560n/a1 site📍 Bron Hospices Civils de Lyon · Tests: Clinical Data An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency NCT07644832Phase 1, Phase 29 sites📍 Changsha📍 Hefei📍 Jinan Shanghai RAAS Blood Products Co., Ltd. · Tests: SR604, SR604, SR604 Hemophilia A Research Program NCT07414511n/a1 site📍 Seattle University of Washington Multidimensional Assessment of Chronic Pain in Severe Haemophilia A NCT07096349n/a1 site📍 Oviedo Investigación en Hemofilia y Fisioterapia Safety of KN057 Prophylaxis in Patients With Haemophilia A or B NCT07545395Phase 31 site📍 Tianjin Suzhou Alphamab Co., Ltd. · Tests: KN057 Longitudinal Cohort of Thrombosis and Hemostasis Diseases NCT06727669n/a5 sites📍 Beijing📍 Beijing📍 Beijing Peking University People's Hospital The European Paediatric Network for Haemophilia Management ( PedNet Registry) NCT02979119n/a39 sites📍 Graz📍 Vienna📍 Leuven PedNet Haemophilia Research Foundation Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy NCT06941870Phase 414 sites📍 Los Angeles📍 Indianapolis📍 Iowa City Sanofi · Tests: Efanesoctocog alfa SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis NCT04563520Phase 32 sites📍 Atlanta📍 Atlanta Emory University · Tests: Emicizumab, FEIBA, rFVIIa Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery NCT05936580Phase 416 sites📍 San Antonio📍 Helsinki📍 Chambray-lès-Tours Octapharma · Tests: Nuwiq
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy